Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akira Shimada

Showing results (21-30 of 360) with videos related to

Pageof 36
Sort By:
Internal Medicine (Tokyo, Japan)|December 3, 2013
Slowly progressive type 1 diabetes treated with metformin for five years after onsetTakumi Hirata, Akira Shimada, Jiro Morimoto, et al.
Journal of Diabetes Investigation|July 30, 2023
Real-world risk of cardiovascular diseases in patients with type 2 diabetes associated with sodium-glucose cotransporter 2 inhibitors in comparison with metformin: A propensity score-matched model analysis in JapanTakeshi Horii, Yoichi Oikawa, Akira Shimada, et al.
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 15, 2007
[Chronic kidney diseases and other diseases: 6. Obesity]Toshihide Kawai, Akira Shimada, Yoichi Oikawa, et al.
Diabetes Care|May 20, 2008
GAD65 autoantibody responses in Japanese latent autoimmune diabetes in adult patientsTaro Maruyama, Shilpa Oak, Akira Shimada, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 7, 2021
[A survey of fertility preservation in patients with hematologic malignancies in the Chugoku and Shikoku regions]Chihiro Kamoi, Nobuharu Fujii, Akira Shimada, et al.
Diabetology International|January 29, 2025
Mitochondrial DNA 3243 mutation may be associated with positivity of zinc transporter 8 autoantibody in cases of slowly progressive type 1 diabetes mellitusErika Mitsui, Atsushi Satomura, Yoichi Oikawa, et al.
Journal of Diabetes Investigation|October 12, 2018
Actual condition survey regarding mismatch of measurements between radioimmunoassay and enzyme-linked immunosorbent assay tests for anti-glutamic acid decarboxylase antibody in real-world clinical practiceYoichi Oikawa, Takuma Kondo, Akira Shimada, et al.
Journal of Diabetes Investigation|May 9, 2022
Combination of anti-CD25 antibody and poly I:C treatment in pregnant NOD mice may be used as 'pregnancy-related' type 1 diabetes modelAkira Shimada, Kyoko Toda, Ikuo Inoue, et al.
Journal of Diabetes Investigation|September 20, 2022
Real-world risk of lower-limb amputation associated with sodium-glucose cotransporter 2 inhibitors versus metformin: A propensity score-matched model analysis in JapanGen Mizutani, Takeshi Horii, Yoichi Oikawa, et al.
BMJ Open Diabetes Research & Care|November 28, 2020
Real-world risk of hypoglycemia-related hospitalization in Japanese patients with type 2 diabetes using SGLT2 inhibitors: a nationwide cohort studyTakeshi Horii, Yoichi Oikawa, Narumi Kunisada, et al.
Pageof 36

Showing results (21-30 of 360) with videos related to

Sort By:
Pageof 36
Internal Medicine (Tokyo, Japan)|December 3, 2013
Slowly progressive type 1 diabetes treated with metformin for five years after onsetTakumi Hirata, Akira Shimada, Jiro Morimoto, et al.
Journal of Diabetes Investigation|July 30, 2023
Real-world risk of cardiovascular diseases in patients with type 2 diabetes associated with sodium-glucose cotransporter 2 inhibitors in comparison with metformin: A propensity score-matched model analysis in JapanTakeshi Horii, Yoichi Oikawa, Akira Shimada, et al.
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 15, 2007
[Chronic kidney diseases and other diseases: 6. Obesity]Toshihide Kawai, Akira Shimada, Yoichi Oikawa, et al.
Diabetes Care|May 20, 2008
GAD65 autoantibody responses in Japanese latent autoimmune diabetes in adult patientsTaro Maruyama, Shilpa Oak, Akira Shimada, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 7, 2021
[A survey of fertility preservation in patients with hematologic malignancies in the Chugoku and Shikoku regions]Chihiro Kamoi, Nobuharu Fujii, Akira Shimada, et al.
Diabetology International|January 29, 2025
Mitochondrial DNA 3243 mutation may be associated with positivity of zinc transporter 8 autoantibody in cases of slowly progressive type 1 diabetes mellitusErika Mitsui, Atsushi Satomura, Yoichi Oikawa, et al.
Journal of Diabetes Investigation|October 12, 2018
Actual condition survey regarding mismatch of measurements between radioimmunoassay and enzyme-linked immunosorbent assay tests for anti-glutamic acid decarboxylase antibody in real-world clinical practiceYoichi Oikawa, Takuma Kondo, Akira Shimada, et al.
Journal of Diabetes Investigation|May 9, 2022
Combination of anti-CD25 antibody and poly I:C treatment in pregnant NOD mice may be used as 'pregnancy-related' type 1 diabetes modelAkira Shimada, Kyoko Toda, Ikuo Inoue, et al.
Journal of Diabetes Investigation|September 20, 2022
Real-world risk of lower-limb amputation associated with sodium-glucose cotransporter 2 inhibitors versus metformin: A propensity score-matched model analysis in JapanGen Mizutani, Takeshi Horii, Yoichi Oikawa, et al.
BMJ Open Diabetes Research & Care|November 28, 2020
Real-world risk of hypoglycemia-related hospitalization in Japanese patients with type 2 diabetes using SGLT2 inhibitors: a nationwide cohort studyTakeshi Horii, Yoichi Oikawa, Narumi Kunisada, et al.
Pageof 36